Moderna's cancer vaccine wins an FDA boon, but shares drop on mixed earnings
Graphite Bio cuts sickle cell therapy, half of staff
Gilead Sciences reports positive data from HIV therapy trial
AstraZeneca doubles down on hot cancer target
*please scroll down for all the latest news*
